Skip to main content

Neurexis Therapeutics

Aurora, United States

Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.

$3.0M raised
Sep 2024
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neurexis Therapeutics

How much funding has Neurexis Therapeutics raised?
Neurexis Therapeutics has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Who are Neurexis Therapeutics's investors?
Neurexis Therapeutics's investors include VIC Technology Venture Development, National Institute of Neurological Disorders and Stroke, Colorado Office of Economic Development and International Trade.
Where is Neurexis Therapeutics headquartered?
Neurexis Therapeutics is headquartered in Aurora, United States.
What does Neurexis Therapeutics do?
Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.
What stage is Neurexis Therapeutics at?
Neurexis Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Neurexis Therapeutics — Funding & Investors." VCBacked, September 16, 2024, https://www.vcbacked.co/company/neurexis-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). Neurexis Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neurexis-therapeutics
Wikipedia (cite web)
{{cite web |title=Neurexis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neurexis-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .